The renal fractional clearance of platinum antitumour compounds in relation to nephrotoxicity.

No abstract is available for this paper.

• Publication year

  1985

• Venue

  Biochemical Pharmacology

• Publication date

  1985-05-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1016/0006-2952(85)90679-3PMID 4039567
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Cisplatin metabolites in plasma, a study of their pharmacokinetics and importance in the nephrotoxic and antitumour activity of cisplatin.

  1984cited by this paper
• Enhancement of cisplatin nephrotoxicity by probenecid.

  1984cited by this paper
• Pharmacokinetics of cis-diammine-1,1-cyclobutane dicarboxylate platinum(II) in patients with normal and impaired renal function.

  1984cited by this paper
• Cisplatin metabolites: a method for their separation and for measurement of their renal clearance in vivo.

  1983cited by this paper
• Effect of probenecid and N'-methylnicotinamide on renal handling of cis-dichlorodiammineplatinum-II in rats.

  1983cited by this paper
• The mechanism of renal clearance of cisplatin (cis-dichlorodiammine platinum ii) and its modification by furosemide and probenecid.

  1982cited by this paper
• Renal handling of cis-diamminedichloroplatinum(II).

  1980cited by this paper
• Modification of the renal toxicity of cis-dichlorodiammineplatinum(II) with furosemide in male F344 rats.

  1977cited by this paper
• Mechanisms of Inorganic Reactions

  1958cited by this paper
• A new method for the determination of inulin in plasma and urine.

  1956cited by this paper

• Understanding Cisplatin Pharmacokinetics and Toxicodynamics to Predict and Prevent Kidney Injury

  2024cites this paper
• Solute Carrier Transportome in Chemotherapy-Induced Adverse Drug Reactions.

  2020cites this paper
• Identification of OAT1/OAT3 as Contributors to Cisplatin Toxicity

  2017cites this paper
• Liquid Chromatography Electrospray Ionization Tandem Mass Spectrometric (LC/ESI-MS/MS) Study for the Identification and Characterization of In Vivo Metabolites of Cisplatin in Rat Kidney Cancer Tissues: Online Hydrogen/Deuterium (H/D) Exchange Study

  2015cites this paper
• Comparative Pharmacokinetics and Allometric Scaling of Carboplatin in Different Avian Species

  2015cites this paper
• Distribution study of cisplatin in rat kidney and liver cancer tissues by using liquid chromatography electrospray ionization tandem mass spectrometry.

  2015cites this paper
• Investigation on pharmacokinetics, tissue distribution and excretion of a novel platinum anticancer agent in rats by Inductively Coupled Plasma Mass Spectrometry (ICP-MS)

  2014cites this paper
• Cellular Mechanisms of Drug Nephrotoxicity

  2013cites this paper
• Nephrotoxicity—What Do We Know and What Don't We Know?

  2011cites this paper
• Nephrotoxicity of cancer treatment in children

  2010cites this paper
• Responses of the Kidney to Toxic Compounds

  2009cites this paper
• CHAPTER 87 – Cellular Mechanisms of Drug Nephrotoxicity

  2008cites this paper
• Intracellular metabolites of cisplatin in the rat kidney

  2004cites this paper
• Effect of glomerular filtration rate on clearance and myelotoxicity of carboplatin in cats with tumors.

  2004cites this paper
• Cellular and molecular aspects of drugs of the future: oxaliplatin

  2002cites this paper
• Interactions of antitumoral platinum-group metallodrugs with albumin

  2002cites this paper
• Drugs of the Future: Review Cellular and molecular aspects of drugs of the future: oxaliplatin

  2002cites this paper
• Pharmacokinetics and Toxicodynamics of Cisplatin and Its Metabolites in Rats: Relationship between Renal Handling and Nephrotoxicity of Cisplatin

  2000cites this paper
• Carrier-mediated uptake of cisplatin by the OK renal epithelial cell line.

  2000cites this paper
• Lack of cisplatin-ranitidine kinetic interactions: in vivo study in children, and in vitro study using dog renal brush border membrane vesicles.

  1998cites this paper
• Clinical Pharmacokinetics and Dose Optimisation of Carboplatin

  1997cites this paper
• Effects of betamipron on cisplatin nephrotoxicity and its pharmacokinetics in rats.

  1997cites this paper
• Biotransformation of the platinum drug JM216 following oral administration to cancer patients

  1996cites this paper
• Quantitative determination of unchanged cisplatin in rat kidney and liver by high-performance liquid chromatography.

  1995cites this paper
• Inorganic Anticancer Agents: Their Chemistry and Antitumor Properties

  1995cites this paper
• Cisplatin nephrotoxicity.

  1994cites this paper
• Reversible and irreversible interactions of a cisplatin analog bearing a 1,2-diphenylethylenediamine ligand with plasma and plasma proteins in vitro.

  1994cites this paper
• Correlation of total and interstrand DNA adducts in tumor and kidney with antitumor efficacies and differential nephrotoxicities of cis-ammine/cyclohexylamine-dichloroplatinum(II) and cisplatin.

  1994cites this paper
• Cytostatics — induced tubular toxicity

  1993influential citation
• Drug nephrotoxicity--the significance of cellular mechanisms.

  1993cites this paper
• Drug nephrotoxicity — The significance of cellular mechanisms

  1993cites this paper
• Nephrotoxicity and hydration management for cisplatin, carboplatin, and ormaplatin.

  1993cites this paper
• Beneficial effect of acetylcysteine on cisplatin nephrotoxicity in rats

  1993cites this paper
• Ultrastructural Alterations and DNA Synthesis of Renal Cell Nuclei following Cisplatin or Carboplatin Injection in Rats

  1992cites this paper
• Comparative study of cisplatin and carboplatin on pharmacokinetics, nephrotoxicity and effect on renal nuclear DNA synthesis in rats.

  1992cites this paper
• A comparative binding of platinum anti-tumour compounds to plasma proteins in the rat (in vivo) and mouse (in vitro).

  1992cites this paper
• The use of probenecid as a chemoprotector against cisplatin nephrotoxicity

  1991cites this paper
• Reaction kinetics of cisplatin and its monoaquated species with the modulating agents (di)mesna and thiosulphate.

  1991cites this paper
• Triiodothyronine (T3) increases cisplatin nephrotoxicity in young and adult rats

  1990cites this paper
• Effect of cis-platinum on heme, drug, and steroid metabolism pathways: possible involvement in nephrotoxicity and infertility.

  1990cites this paper
• Analytical methodologies for the quantitation of platinum anti-cancer drugs and related compounds in biological media.

  1990cites this paper
• Age dependent differences in the functional and morphological impairment of kidney following cisplatin administration.

  1990cites this paper
• Biochemical modulation of cisplatin toxicity.

  1989cites this paper
• Comparative distribution and excretion of carboplatin and cisplatin in mice

  1988cites this paper
• Clinical and Experimental Nephrotoxicity of Cancer Chemotherapeutic Agents

  1987cites this paper
• The comparative pharmacokinetics of carboplatin and cisplatin in mice and rats.

  1987cites this paper
• Analysis of platinum species originating from cis-diamminedichloroplatinum(II) (cisplatin) in human and rat plasma by high-performance liquid chromatography with on-line inductively coupled plasma atomic emission spectrometric detection.

  1987cites this paper